Pharmacokinetics of Carnosine

This study has been completed.
Sponsor:
Information provided by:
Tufts University
ClinicalTrials.gov Identifier:
NCT00721708
First received: July 22, 2008
Last updated: December 14, 2009
Last verified: December 2009
  Purpose

The absorption kinetics of dietary carnosine (β-alanyl-L-histidine) will be determined in the healthy adults.


Condition Intervention
Oxidative Stress
Dietary Supplement: pure carnosine
Other: Beef
Other: Chicken
Other: Chicken broth

Study Type: Interventional
Study Design: Endpoint Classification: Pharmacokinetics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Official Title: Pharmacokinetics of Carnosine

Further study details as provided by Tufts University:

Primary Outcome Measures:
  • Plasma histidine-dipeptide [ Time Frame: 0, 30, 60, 100, 180, 240, & 300 min ] [ Designated as safety issue: No ]

Enrollment: 4
Study Start Date: April 2007
Study Completion Date: July 2008
Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Carnosine(450 mg)
Dietary Supplement: pure carnosine
one time dose of pure carnosine (450 mg)
Experimental: 2
Beef (150g)
Other: Beef
one time dose, 150 g of beef
Experimental: 3
chicken (150g)
Other: Chicken
One time dose, 150g of chicken breast
Experimental: 4
Chicken broth (obtained from 150 g of chicken breast)
Other: Chicken broth
one time dose of chicken broth obtained from 150g of chicken breast

  Eligibility

Ages Eligible for Study:   40 Years to 70 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy adult
  • normal hematological parameters, normal serum albumin, normal liver function, normal kidney function

Exclusion Criteria:

  • History of smoking or alcoholism
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00721708

Locations
United States, Massachusetts
Jean Mayer USDA-Human Nutrition Research Center on Aging at Tufts University
Boston, Massachusetts, United States, 02111
Sponsors and Collaborators
Tufts University
Investigators
Principal Investigator: Kyung-Jin Yeum, Ph.D. Tufts Medical Center
  More Information

Publications:
Responsible Party: Kyung-Jin Yeum, Scientist, Tufts University
ClinicalTrials.gov Identifier: NCT00721708     History of Changes
Other Study ID Numbers: TMC/TUHS IRB 7737
Study First Received: July 22, 2008
Last Updated: December 14, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Tufts University:
histidine dipeptides
carnosine
anserine

ClinicalTrials.gov processed this record on May 23, 2013